(Q34150263)

English

Clofarabine in leukemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Clofarabine in leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

6

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

object named as

Stefan Faderl

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

Elias Jabbour

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

William Plunkett

5

object named as

William Plunkett

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

object named as

Hady Ghanem

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Varsha Ghandhi

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Expert Review of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

15-22

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Antitumor activity of 2-fluoro-2'-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Preclinical antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)adenine (Cl-F-ara-A).

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Biochemical modulation of cytarabine triphosphate by clofarabine.

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Clofarabine combinations as acute myeloid leukemia salvage therapy

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1586%2FEHM.09.70

21 January 2018

Identifiers

10.1586/EHM.09.70

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34150263&oldid=1980873832"